Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Scancell Holdings plc
DescriptionPeptide vaccine comprised of two modified vimentin peptides
Molecular Target Vimentin (VIM)
Mechanism of Action 
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today